- Home
- ATYR vs OKYO Comparison
ATYR vs OKYO Comparison
Compare ATYR & OKYO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | ATYR | OKYO |
|---|---|---|
| Founded | 2005 | 2007 |
| Country | United States | United Kingdom |
| Employees | 58 | N/A |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Biotechnology: Biological Products (No Diagnostic Substances) |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 73.7M | 85.3M |
| IPO Year | N/A | 2021 |
Fundamental Metrics
Financial Performance| Metric | ATYR | OKYO |
|---|---|---|
| Price | $0.75 | $1.53 |
| Analyst Decision | Hold | Strong Buy |
| Analyst Count | 8 | 3 |
| Target Price | $4.20 | ★ $6.33 |
| AVG Volume (30 Days) | ★ 985.5K | 94.4K |
| Earning Date | 03-05-2026 | 07-18-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $0.64 | $1.03 |
| 52 Week High | $7.29 | $3.35 |
Technical Indicators
Market Signals| Indicator | ATYR | OKYO |
|---|---|---|
| Relative Strength Index (RSI) | 37.34 | 37.59 |
| Support Level | $0.67 | $1.53 |
| Resistance Level | $0.85 | $1.74 |
| Average True Range (ATR) | 0.05 | 0.13 |
| MACD | -0.01 | 0.00 |
| Stochastic Oscillator | 1.23 | 32.08 |
Price Performance
Historical ComparisonAbout ATYR aTyr Pharma Inc.
aTyr Pharma Inc is a clinical-stage biotechnology company focused on developing therapies for fibrosis and inflammatory conditions. Its research leverages tRNA synthetase biology to identify potential therapeutic targets. The company's discovery platform uses a proprietary library of domains derived from tRNA synthetases to explore signaling pathways. Its flagship clinical candidate, efzofitimod, is a novel biologic immunomodulatory in development for the treatment of interstitial lung disease (ILD).
About OKYO OKYO Pharma Limited
OKYO Pharma Ltd is a biopharmaceutical company. The company is developing therapeutics to improve the lives of patients with inflammatory eye diseases and chronic pain. It offers solutions for various diseases such as Dry Eye Disease, Non-infectious Anterior Uveitis, Allergenic Conjunctivitis, Chronic Pain, and Ocular Pain.